Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calibr-Skaggs Institute for Innovative Medicines
La Jolla, California, United Statescalibr.scripps.edu ↗
- Ownership
- Private
- Employees
- ~174
- Development stage
- Other
01
Overview
Calibr has advanced over ten programs into clinical development with several more in IND-enabling studies. Their portfolio includes first-in-class approaches such as switchable CAR-T therapies and novel small molecule or biologic candidates targeting a range of unmet medical needs from rare fibrotic disorders to metabolic syndrome. The institute’s self-sustaining model reinvests licensing revenues back into research to accelerate translation from bench to bedside[1][6].
- Therapeutic areas
- GastroenterologyPulmonologyMetabolic DisordersImmunologyEndocrinologyOncologyInfectious Diseases
- Modalities
- Small moleculesbiologicscell therapiesoral peptideslong-acting injectables
- Industry
- Academic Hospital/University/Research
02
Partnerships
Merck & Co. ($90M initial funding/licensing option)[5]Bristol Myers Squibb (fibrosis collaboration/license)[10]AbbVie [6]Bill & Melinda Gates Foundation [6]ArkBio [2]
Beyond the preview
Go deeper on Calibr-Skaggs Institute for Innovative Medicines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calibr-Skaggs Institute for Innovative Medicines.